Lentiviral vector design for multiple shRNA expression and durable HIV-1 inhibition

Molecular Therapy

Volumn 16, Issue 3, 2008, Pages 557-564

  ter Brake, Olivier ^a   't Hooft, Karen ^a   Liu, Ying Poi ^a   Centlivre, Mireille ^a   von Eije, Karin Jasmijn ^a   Berkhout, Ben ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DNA DIRECTED RNA POLYMERASE III; LENTIVIRUS VECTOR; RNA POLYMERASE; RNA POLYMERASE II; SHORT HAIRPIN RNA;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; GENE DELETION; GENE EXPRESSION; GENE SEQUENCE; GENE TRANSFER; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; PROMOTER REGION; RNA INTERFERENCE; RNA RECOMBINATION; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; VIRUS INHIBITION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 39849108343     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/sj.mt.6300382     Document Type: Article

References (50)

1. O ter Brake B Berkhout A novel approach for inhibition of HIV-1 by RNA interference: counteracting viral escape with a second generation of siRNAs J RNAi Gene Silencing 1 2005 56 65
2. B Berkhout J Haasnoot The interplay between virus infection and the cellular RNA interference machinery FEBS Lett 580 2006 2896 2902
3. V Bitko A Musiyenko O Shulyayeva S Barik Inhibition of respiratory viruses by nasally administered siRNA Nat Med 11 2005 50 55
4. TR Brummelkamp R Bernards R Agami A system for stable expression of short interfering RNAs in mammalian cells Science 296 2002 550 553
5. T Yamamoto H Miyoshi N Yamamoto N Yamamoto J Inoue Y Tsunetsugu-Yokota Lentivirus vectors expressing short hairpin RNAs against the U3-overlapping region of HIV nef inhibit HIV replication and infectivity in primary macrophages Blood 108 2006 3305 3312
6. MJ Li G Bauer A Michienzi JK Yee NS Lee J Kim Inhibition of HIV-1 infection by lentiviral vectors expressing Pol III-promoted anti-HIV RNAs Mol Ther 8 2003 196 206
7. D Boden O Pusch F Lee L Tucker B Ramratnam Human immunodeficiency virus type 1 escape from RNA interference J Virol 77 2003 11531 11535
8. HJ Unwalla HT Li I Bahner MJ Li D Kohn JJ Rossi Novel Pol II fusion promoter directs human immunodeficiency virus type 1-inducible coexpression of a short hairpin RNA and protein J Virol 80 2006 1863 1873
9. O ter Brake P Konstantinova M Ceylan B Berkhout Silencing of HIV-1 with RNA interference: a multiple shRNA approach Mol Ther 14 2006 883 892
10. EM Westerhout M Ooms M Vink AT Das B Berkhout HIV-1 can escape from RNA interference by evolving an alternative structure in its RNA genome Nucleic Acids Res 33 2005 796 804
11. AT Das TR Brummelkamp EM Westerhout M Vink M Madiredjo R Bernards Human immunodeficiency virus type 1 escapes from RNA interference-mediated inhibition J Virol 78 2004 2601 2605
12. B Berkhout RNA interference as an antiviral approach: targeting HIV-1 Curr Opin Mol Ther 6 2004 141 145
13. JN Leonard DV Schaffer Computational design of antiviral RNA interference strategies that resist human immunodeficiency virus escape J Virol 79 2005 1645 1654
14. SG Deeks Antiretroviral treatment of HIV infected adults BMJ 332 2006 1489
15. BR Schackman KA Gebo RP Walensky E Losina T Muccio PE Sax The lifetime cost of current human immunodeficiency virus care in the United States Med Care 44 2006 990 997
16. D Grimm MA Kay Combinatorial RNAi: a winning strategy for the race against evolving targets? Mol Ther 15 2007 878 888
17. Y Liu J Haasnoot B Berkhout Design of extended short hairpin RNAs for HIV-1 inhibition Nucleic Acids Res 35 2007 5683 5693
18. P Konstantinova W de Vries J Haasnoot O ter Brake P de Haan B Berkhout Inhibition of human immunodeficiency virus type 1 by RNA interference using long-hairpin RNA Gene Ther 13 2006 1403 1413
19. SD Henry WP van der HJ Metselaar HW Tilanus BJ Scholte LJ van der Laan Simultaneous targeting of HCV replication and viral binding with a single lentiviral vector containing multiple RNA interference expression cassettes Mol Ther 14 2006 485 493
20. SQ Harper PD Staber X He SL Eliason IH Martins Q Mao RNA interference improves motor and neuropathological abnormalities in a Huntington's disease mouse model Proc Natl Acad Sci USA 102 2005 5820 5825
21. GS Ralph PA Radcliffe DM Day JM Carthy MA Leroux DC Lee Silencing mutant SOD1 using RNAi protects against neurodegeneration and extends survival in an ALS model Nat Med 11 2005 429 433
22. –/– mice: functional inactivation of p53 in developing T cells Blood 104 2004 3886 3893
23. C van den Haute K Eggermont B Nuttin Z Debyser V Baekelandt Lentiviral vector-mediated delivery of short hairpin RNA results in persistent knockdown of gene expression in mouse brain Hum Gene Ther 14 2003 1799 1807
24. O ter Brake B Berkhout Lentiviral vectors that carry anti-HIV shRNAs: problems and solutions J Gene Med 9 2007 743 750
25. MJ Li J Kim S Li J Zaia JK Yee J Anderson Long-term inhibition of HIV-1 infection in primary hematopoietic cells by lentiviral vector delivery of a triple combination of anti-HIV shRNA, anti-CCR5 ribozyme, and a nucleolar-localizing TAR decoy Mol Ther 12 2005 900 909
26. J Anderson MJ Li B Palmer L Remling S Li P Yam Safety and efficacy of a lentiviral vector containing three anti-HIV genes—CCR5 ribozyme, tat-rev siRNA, and TAR decoy—in SCID-hu mouse-derived T cells Mol Ther 15 2007 1182 1188
27. W An A Telesnitsky Frequency of direct repeat deletion in a human immunodeficiency virus type 1 vector during reverse transcription in human cells Virology 286 2001 475 482
28. G Marzio K Verhoef M Vink B Berkhout In vitro evolution of a highly replicating, doxycycline-dependent HIV for applications in vaccine studies Proc Natl Acad Sci USA 98 2001 6342 6347
29. J Zhuang AE Jetzt G Sun H Yu G Klarmann Y Ron Human immunodeficiency virus type 1 recombination: rate, fidelity, and putative hot spots J Virol 76 2002 11273 11282
30. AE Jetzt H Yu GJ Klarmann Y Ron BD Preston JP Dougherty High rate of recombination throughout the human immunodeficiency virus type 1 genome J Virol 74 2000 1234 1240
31. JY Yu SL DeRuiter DL Turner RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells Proc Natl Acad Sci USA 99 2002 6047 6052
32. D Koper-Emde L Herrmann B Sandrock BJ Benecke RNA interference by small hairpin RNAs synthesised under control of the human 7S K RNA promoter Biol Chem 385 2004 791 794
33. MA Denti A Rosa O Sthandier FG De Angelis I Bozzoni A new vector, based on the PolII promoter of the U1 snRNA gene, for the expression of siRNAs in mammalian cells Mol Ther 10 2004 191 199
34. D Castanotto K Sakurai R Lingeman H Li L Shively L Aagaard Combinatorial delivery of small interfering RNAs reduces RNAi efficacy by selective incorporation into RISC Nucleic Acids Res 35 2007 5154 5164
35. E Kotsopoulou VN Kim AJ Kingsman SM Kingsman KA Mitrophanous A Rev-independent human immunodeficiency virus type 1 (HIV-1)-based vector that exploits a codon-optimized HIV-1 gag-pol gene J Virol 74 2000 4839 4852
36. M Kumar B Keller N Makalou RE Sutton Systematic determination of the packaging limit of lentiviral vectors Hum Gene Ther 12 2001 1893 1905
37. K Peden M Emerman L Montagnier Changes in growth properties on passage in tissue culture of viruses derived from infectious molecular clones of HIV-1LAI, HIV-1MAL, and HIV-1ELI Virology 185 1991 661 672
38. M Llano DT Saenz A Meehan P Wongthida M Peretz WH Walker An essential role for LEDGF/p75 in HIV integration Science 314 2006 461 464
39. J Anderson R Akkina HIV-1 resistance conferred by siRNA cosuppression of CXCR4 and CCR5 coreceptors by a bispecific lentiviral vector AIDS Res Ther 2 2005 1
40. D Boden O Pusch F Lee L Tucker PR Shank B Ramratnam Promoter choice affects the potency of HIV-1 specific RNA interference Nucleic Acids Res 31 2003 5033 5038
41. J Song S Pang Y Lu R Chiu Poly(U) and polyadenylation termination signals are interchangeable for terminating the expression of shRNA from a pol II promoter Biochem Biophys Res Commun 323 2004 573 578
42. EM Westerhout O ter Brake B Berkhout The virion-associated incoming HIV-1 RNA genome is not targeted by RNA interference Retrovirology 3 2006 57
43. RM Surabhi RB Gaynor RNA interference directed against viral and cellular targets inhibits human immunodeficiency Virus Type 1 replication J Virol 76 2002 12963 12973
44. N Legrand K Weijer H Spits Experimental models to study development and function of the human immune system in vivo J Immunol 176 2006 2053 2058
45. –/– (RAG-hu) mouse model Retrovirology 3 2006 76
46. S Watanabe K Terashima S Ohta S Horibata M Yajima Y Shiozawa Hematopoietic stem cell-engrafted NOD/SCID/IL2Rgamma null mice develop human lymphoid systems and induce long-lasting HIV-1 infection with specific humoral immune responses Blood 109 2007 212 218
47. DS Strayer R Akkina BA Bunnell B Dropulic V Planelles RJ Pomerantz Current status of gene therapy strategies to treat HIV/AIDS Mol Ther 11 2005 823 842
48. R Wolkowicz GP Nolan Gene therapy progress and prospects: novel gene therapy approaches for AIDS Gene Ther 12 2005 467 476
49. BL Levine LM Humeau J Boyer RR MacGregor T Rebello X Lu Gene transfer in humans using a conditionally replicating lentiviral vector Proc Natl Acad Sci USA 103 2006 17372 17377
50. J Seppen M Rijnberg MP Cooreman RP Oude Elferink Lentiviral vectors for efficient transduction of isolated primary quiescent hepatocytes J Hepatol 36 2002 459 465